特发性肺纤维化临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 特发性肺纤维化（国际通用名 idiopathic pulmonary fibrosis）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖肺纤维化、IPF等说法。

正在招募的特发性肺纤维化新药试验

• Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole

  III 期招募中英国NCT04965298

• Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

  II 期招募中美国澳大利亚Bulgaria加拿大NCT07230288

• Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

  I 期招募中美国NCT04362644

• Mechanisms of Familial Pulmonary Fibrosis

  不适用招募中美国NCT03437486

• Downhill Walking in IPF

  不适用招募中Turkey (Türkiye)NCT06756230

• Interstitial Lung Disease Research Unit Biobank

  不适用招募中美国NCT05392881

• Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis

  II 期招募中美国NCT06567717

• A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

  III 期招募中中国NCT07464912

• Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

  II 期招募中DenmarkEstonia英国NCT06714123

• End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical Ventilation

  不适用招募中意大利NCT05098717

• Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

  不适用招募中美国NCT01776398

• A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

  II 期招募中美国Argentina澳大利亚BulgariaNCT07652658